The clinicians at the Cancer Treatment Centers of America® (CTCA) GI Cancer Center in Atlanta are committed to offering state-of-the-art treatments for patients with gastrointestinal cancer. Our multidisciplinary team of board-certified medical oncologists, surgical oncologists, radiation oncologists and supportive care clinicians work with our patients to deliver quality clinical care with a patient-centered approach. After your diagnosis, your GI Cancer Center care team will discuss your options with you and help you develop a personalized care plan tailored to your individual needs.
Our doctors are trained and experienced at treating the wide range of gastrointestinal diseases, including colorectal, bile duct, liver, anal, pancreatic and gastroesophageal cancers. Treatments for most gastrointestinal diseases include chemotherapy, radiation, surgery, targeted therapy or immunotherapy, either alone or in combination.
At the GI Cancer Center, our surgical oncologists have expertise in standard-of-care and advanced treatment procedures, including a surgical technique called irreversible electroporation, which is used to treat certain pancreatic cancers that can't be removed with surgery. Irreversible electroporation is designed to use electric pulses to destroy cancer cells without damaging healthy tissue. For patients with advanced colorectal, appendix or stomach cancer, surgery to reduce the size of a tumor may be recommended in combination with hyperthermic intraperitoneal chemotherapy (HIPEC), a highly concentrated, heated chemotherapy treatment delivered directly to the abdominal cavity during surgery. For patients with early-stage esophageal cancer or non-cancerous polyps in the intestines, our gastroenterologists combine state-of-the-art technologies with non-surgical techniques, such as endoscopic mucosal resection, to remove abnormal tissue. They also use a wide range of tools, such as endoscopic ultrasound with fine needle biopsy and radiofrequency ablation, to treat esophageal, pancreatic, bile duct and colorectal cancers.
Learn more about our neuroendocrine tumor program here.